» Articles » PMID: 6616441

The Selective Nature of Metastasis

Overview
Specialty Oncology
Date 1983 Jan 1
PMID 6616441
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The issue of whether metastases result from the random survival of cells released from a primary tumor or from the selective growth of specialized tumor subpopulations endowed with metastatic properties is important to our understanding of the metastatic process and to the development of therapeutic modalities against metastatic disease. We have found that the tumor cells populating spontaneous metastases are more metastatic than the cells populating the parent neoplasm, clearly indicating that metastasis is selective and not random. The selective nature of metastasis is a consistent observation, however, only when tumor cells are obtained from spontaneous metastases from mice bearing heterogenous, poorly metastatic tumors. Tumor cells from spontaneous metastases from mice bearing tumors that have been selected for metastatic potential or that are homogeneous (cloned) do not differ significantly in metastatic potential from tumor cells populating the parent tumor. Thus, under some conditions the process of metastasis can appear random. Although tumor cells from different individual metastases may be homogeneous with regard to a metastatic phenotype, they may be heterogeneous with regard to their sensitivity to chemotherapeutic agents. Thus, although metastasis selects for metastatic variants, resulting in the population of metastatic foci with tumor cells endowed with metastatic properties, it does not appear to select for phenotypes irrelevant to the process of metastasis such as sensitivity to therapeutic agents.

Citing Articles

Disaggregation and invasion of ovarian carcinoma ascites spheroids.

Burleson K, Boente M, Pambuccian S, Skubitz A J Transl Med. 2006; 4:6.

PMID: 16433903 PMC: 1397876. DOI: 10.1186/1479-5876-4-6.


N-linked oligosaccharides and metastatic propensity in in vivo selected mouse mammary adenocarcinoma cells.

Seberger P, Scholar E, Kelsey L, Chaney W, Talmadge J Clin Exp Metastasis. 2000; 17(5):437-44.

PMID: 10651311 DOI: 10.1023/a:1006629119030.


Antimetastatic action and toxicity on healthy tissues of Na[trans-RuCl4(DMSO)Im] in the mouse.

Gagliardi R, Sava G, Pacor S, Mestroni G, Alessio E Clin Exp Metastasis. 1994; 12(2):93-100.

PMID: 8306532 DOI: 10.1007/BF01753975.


Heterogeneity in a spontaneous mouse lung carcinoma: selection and characterisation of stable metastatic variants.

Layton M, FRANKS L Br J Cancer. 1984; 49(4):415-21.

PMID: 6324836 PMC: 1976760. DOI: 10.1038/bjc.1984.67.


Quantitative genetic analysis of tumor progression.

Ling V, Chambers A, Harris J, Hill R Cancer Metastasis Rev. 1985; 4(2):173-92.

PMID: 3893685 DOI: 10.1007/BF00050694.


References
1.
Fidler I, Hart I . Biological and experimental consequences of the zonal composition of solid tumors. Cancer Res. 1981; 41(8):3266-7. View

2.
Fidler I, Kripke M . Metastasis results from preexisting variant cells within a malignant tumor. Science. 1977; 197(4306):893-5. DOI: 10.1126/science.887927. View

3.
Tilley W, Keightley D, Cant E . Inter-site variation of oestrogen receptors in human breast cancers. Br J Cancer. 1978; 38(4):544-6. PMC: 2009767. DOI: 10.1038/bjc.1978.242. View

4.
Brunson K, Nicolson G . Selection and biologic properties of malignant variants of a murine lymphosarcoma. J Natl Cancer Inst. 1978; 61(6):1499-503. View

5.
TAO T, Burger M . Non-metastasising variants selected from metastasising melanoma cells. Nature. 1977; 270(5636):437-8. DOI: 10.1038/270437a0. View